Last update :
19/11/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
valistab
valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
References   References 4714  
Type : Poster
Icone.pdf
629Ko
Research teams : Créteil - Henri Mondor University Hospital, Department of Pharmacy
Authors : Vieillard V, Paul M
Title : Etude de stabilité d'un biosimilaire du Bevacizumab dans les flacons et après dilution dans du NaCl 0.9% en poche de polyoléfine.
Reference : GERPAC Congrès - octobre 2022 2022
Level of Evidence : 
Level of evidence A+
Physical stability : 
Turbidimetry Protein: Size Exclusion Chromatography Protein: Dynamic Light Scattering 
Chemical stability : 
Protein: ionic chromatography
Other methods : 
PH measurement Measurement of osmolality 
Comments : 
List of drugs
injectionBevacizumab Anticancer drug
Stability in solutions Glass None 25 mg/ml 20-25°C Protect from light
15 Day
Biosimilar
Stability in solutions partially used vials None 25 mg/ml 4°C Protect from light
60 Day
Biosimilar
Stability in solutions Polyolefine Sodium chloride 0,9% 1,4 & 16,5 mg/ml 25°C Not specified
3 Day
Biosimilar
Stability in solutions Polyolefine Sodium chloride 0,9% 1,4 & 16,5 mg/ml 4°C Protect from light
90 Day
Biosimilar
  Mentions Légales